# LANREOTIDE ACETATE by Amneal Pharmaceuticals LLC: new human prescription drug listing

**Launch Signal Score:** 75/100

| Field | Value |
|---|---|
| Product | LANREOTIDE ACETATE |
| Generic name | LANREOTIDE ACETATE |
| NDC | 70121-2517 |
| Labeler | Amneal Pharmaceuticals LLC |
| Product type | HUMAN PRESCRIPTION DRUG |
| Approval pathway | ANDA |
| Application number | ANDA218217 |
| Dosage form | INJECTION |
| Route | SUBCUTANEOUS |
| Active ingredients | LANREOTIDE ACETATE 120 mg/.5mL |
| Marketing start | 2026-09-23 |
| Package configurations | 1 |

## Why this score
- Prescription or biologic product.
- New generic entry: wholesalers and GPOs re-bid contracts.
- Injectable: hospital and 503B relevance.

Source: U.S. FDA National Drug Code (NDC) Directory via openFDA (https://dailymed.nlm.nih.gov/dailymed/search.cfm?labeltype=all&query=70121-2517). Last refreshed: 2026-11-03T18:09:00.764Z.
Listing data comes from the FDA NDC directory via openFDA; a listing is not an FDA approval or endorsement and may be updated or withdrawn. Informational only; not medical advice.